.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,858,626

« Back to Dashboard

Details for Patent: 7,858,626

Title:Pyrimidineamines as angiogenesis modulators
Abstract: Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Inventor(s): Boloor; Amogh (La Jolla, CA), Cheung; Mui (Wayne, PA), Davis-Ward; Ronda Gayle (North Little Rock, AR), Harris; Philip Anthony (Wayne, PA), Hinkle; Kevin (Phoenixville, PA), Lauderman; Christopher P. (Durham, NC), Mook, Jr.; Robert Anthony (Chapel Hill, NC), Stafford; Jeffery Alan (San Diego, CA), Veal; James Marvin (Apex, NC)
Assignee: GlaxoSmithKline LLC (Philadelphia, PA)
Filing Date:Jul 30, 2007
Application Number:11/830,024
Claims:1. A compound of formula (II): ##STR00124## or a salt thereof, wherein: X.sub.1 is methyl or ethyl; X.sub.2 is hydrogen or methyl; X.sub.3 is hydrogen; X.sub.4 is hydrogen, methyl, or ethyl; W is N; Q.sub.1 is hydrogen, chlorine, or methoxy; Q.sub.2 is A.sup.1 or A.sup.2; Q.sub.3 is A.sup.1 when Q.sub.2 is A.sup.2 and Q.sub.3 is A.sup.2 when Q.sub.2 is A.sup.1; wherein A.sup.1 is hydrogen, methyl, or chlorine, and A.sup.2 is the group defined by -(Z).sub.m-(Z.sup.1)-(Z.sup.2), wherein Z is CH.sub.2 and m is 0, 1, 2, or 3, or Z is NR.sup.2 and m is 0 or 1, or Z is CH.sub.2NR.sup.2 and m is 0 or 1; Z.sup.1 is S(O).sub.2, and Z.sup.2 is C.sub.1-C.sub.4 alkyl or NR.sup.3R.sup.4; and R.sup.2, R.sup.3, and R.sup.4 are each independently selected from hydrogen and C.sub.1-C.sub.4 alkyl.

2. A compound as claimed in claim 1 wherein X.sub.1 is methyl.

3. A compound as claimed in claim 1 wherein X.sub.2 is hydrogen.

4. A compound as claimed in claim 1 wherein X.sub.2 is methyl.

5. A compound as claimed in claim 1 wherein X.sub.4 is methyl.

6. A compound as claimed in claim 1 wherein X.sub.1 is methyl, X.sub.2 is hydrogen, X.sub.3 is hydrogen, and X.sub.4 is methyl.

7. A compound as claimed in claim 1 wherein X.sub.1 is methyl, X.sub.2 is methyl, X.sub.3 is hydrogen, and X.sub.4 is methyl.

8. A compound as claimed in claim 1 wherein Q.sub.1 is hydrogen.

9. A compound as claimed in claim 1 wherein Q.sub.1 is chlorine.

10. A compound as claimed in claim 1 wherein Q.sub.1 is methoxy.

11. A compound as claimed in claim 1 wherein Q.sub.2 is A.sup.1 and Q.sub.3 is A.sup.2.

12. A compound as claimed in claim 1 wherein Q.sub.2 is A.sup.2 and Q.sub.3 is A.sup.1.

13. A compound as claimed in claim 1 wherein Q.sub.2 is A.sup.2 and Q.sub.3 is A.sup.1, wherein A.sup.1 is hydrogen or chlorine and A.sup.2 is the group defined by -(Z).sub.m-(Z.sup.1)-(Z.sup.2), wherein Z is CH.sub.2 and m is 0, 1, 2, or 3; Z.sup.1 is S(O).sub.2; and Z.sup.2 is C.sub.1-C.sub.4 alkyl.

14. A compound as claimed in claim 1 wherein Q.sub.2 is A.sup.1 and Q.sub.3 is A.sup.2, wherein A.sup.1 is hydrogen, methyl, or chlorine and A.sup.2 is the group defined by -(Z).sub.m-Z.sup.1).sub.4Z.sup.2), wherein Z is CH.sub.2 and m is 0, 1, 2, or 3; Z.sup.1 is S(O).sub.2; and Z is C.sub.1-C.sub.4 alkyl or NR.sup.3R.sup.4, wherein R.sup.3 and R.sup.4 are each independently selected from hydrogen or C.sub.1-C.sub.4 alkyl.

15. A compound as claimed in claim 1 selected from the group consisting of: N.sup.2-(3-methyl-1H-indazol-6-yl)-N.sup.4-{3-[(methylsulfonyl)methyl- ]phenyl}-1,3,5-triazine-2,4-diamine trifluoroacetate; N.sup.2-methyl-N.sup.2-(3-methyl-1H-indazol-6-yl)-N.sup.4-4-{3-[(methylsu- lfonyl)methyl]phenyl}-1,3,5-triazine-2,4-diamine; N.sup.2-[5-(ethylsulfonyl)-2-methoxyphenyl]-N.sup.4-methyl-N.sup.4-(3-met- hyl-1H-indazol-6-yl)-1,3,5-triazine-2,4-diamine; N-[2-methyl-5-({4-[methyl(3-methyl-1H-indazol-6-yl)amino]-1,3,5-triazin-2- -yl}amino)phenyl]methanesulfonamide; N.sup.2-methyl-N.sup.2-(3-methyl-1H-indazol-6-yl)-N.sup.4-[3-(methylsulfo- nyl)phenyl]-1,3,5-triazine-2,4-diamine; 3-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-1,3,5-triazin-2-yl}am- ino)benzenesulfonamide; and 5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-1,3,5-triazin-2-yl}am- ino)-2-methylbenzenesulfonamide; or a salt thereof.

16. A pharmaceutical composition, comprising: a therapeutically effective amount of a compound as claimed in claim 1 or a pharmaceutically acceptable salt thereof and one or more of pharmaceutically acceptable carriers, diluents and excipients.

17. The pharmaceutical composition of claim 16, further comprising at least one additional agent that is an anti-neoplastic agent.

18. The pharmaceutical composition of claim 16, further comprising an additional agent that inhibits angiogenesis.

19. A method of treating a disorder in a mammal, said disorder being characterized by inappropriate angiogenesis, wherein said disorder is selected from the group consisting of colon cancer and breast cancer, comprising administering to said mammal a therapeutically effective amount of a compound as claimed in claim 1.

20. A compound as claimed in claim 1, wherein X.sub.1 is methyl, X.sub.2 is hydrogen, X.sub.3 is hydrogen, X.sub.4 is methyl, and Q.sub.1 is hydrogen.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc